TrialBMC medicine2026

Utidelone in patients with advanced soft tissue sarcoma refractory to anthracycline and antiangiogenic therapy (UTISARC): a single-arm phase II study.

Jie Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.